Success Metrics

Clinical Success Rate
85.7%

Based on 6 completed trials

Completion Rate
86%(6/7)
Active Trials
3(23%)
Results Posted
0%(0 trials)
Terminated
1(8%)

Phase Distribution

Ph not_applicable
8
62%
Ph phase_2
1
8%
Ph phase_4
3
23%

Phase Distribution

0

Early Stage

1

Mid Stage

3

Late Stage

Phase Distribution12 total trials
Phase 2Efficacy & side effects
1(8.3%)
Phase 4Post-market surveillance
3(25.0%)
N/ANon-phased studies
8(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

85.7%

6 of 7 finished

Non-Completion Rate

14.3%

1 ended early

Currently Active

3

trials recruiting

Total Trials

13

all time

Status Distribution
Active(4)
Completed(6)
Terminated(1)
Other(2)

Detailed Status

Completed6
unknown2
Recruiting2
Not yet recruiting1
Terminated1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
3
Success Rate
85.7%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (8.3%)
Phase 43 (25.0%)
N/A8 (66.7%)

Trials by Status

unknown215%
not_yet_recruiting18%
terminated18%
active_not_recruiting18%
completed646%
recruiting215%

Recent Activity

Clinical Trials (13)

Drug Details

Intervention Type
DRUG
Total Trials
13